2011. ISPOR Annual International Meeting – Cost-Effectiveness of Abatacept in Comparison with Other Biologic Therapies for the Treatment of Moderate to Severe Active Rheumatoid Arthritis Patients Who Have Failed to Methotrexate Based Treatment at Essalud in 2010

Becerra Rojas F, Benites Chacaltana C, Aiello EC, Zingoni C, Bergman G, Drost P, Valencia JE, Sanabria Montañez C. Cost-Effectiveness of Abatacept in Comparison with Other Biologic Therapies for the Treatment of Moderate to Severe Active Rheumatoid Arthritis Patients Who Have Failed to Methotrexate Based Treatment at Essalud in 2010. Value Health. 2011 May;14(3):A129. Presented at: ISPOR 16th Annual International Meeting; May 24, 2011; Baltimore, USA.